NTRS
39
2
ILMN
36
10
SLG
71
-4
EMC
77
-8
HBI
37
7
F
42
-4
PVH
63
5
GIS
54
2
CVX
23
-2
AVY
74
2
SJM
29
-2
HIG
72
-2
DNB
36
2
PAYX
56
2
PM
52
-4
DHR
50
4
LYB
32
2
CSCO
53
2
SHW
61
2
TROW
48
-2
NTRS
39
2
ILMN
36
10
SLG
71
-4
EMC
77
-8
HBI
37
7
F
42
-4
PVH
63
5
GIS
54
2
CVX
23
-2
AVY
74
2
SJM
29
-2
HIG
72
-2
DNB
36
2
PAYX
56
2
PM
52
-4
DHR
50
4
LYB
32
2
CSCO
53
2
SHW
61
2
TROW
48
-2
Financhill
Back

NewLake Capital Partners Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
72

NLCP
NewLake Capital Partners

Last Price:
20.20
Seasonality Move:
-4.36%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
72
NewLake Capital Partners (NLCP) is a Buy

Is NewLake Capital Partners a Buy, Sell or Hold?

  • The current NewLake Capital Partners [NLCP] share price is $20.20. The Score for NLCP is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • NLCP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLCP Stock Price Chart

What is NewLake Capital Partners's stock price today?

  • The NewLake Capital Partners share price today is $20.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NLCP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 60.26 Buy
Chaikin Money Flow: -889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.1 - 20.16) Buy
Bollinger Bands (100): (16.72 - 19.76) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

NLCP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.79 Buy
20-day SMA: 19.46 Buy
50-day SMA: 19.38 Buy
200-day SMA: 16.22 Buy
8-day EMA: 19.89 Buy
20-day EMA: 19.67 Buy
50-day EMA: 19.26 Buy
200-day EMA: 17.1 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

NewLake Capital Partners Earnings Growth & NLCP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

NewLake Capital Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):